AllianceBernstein’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,731
Closed -$86.1K 3250
2025
Q1
$86.1K Hold
4,731
﹤0.01% 3082
2024
Q4
$176K Hold
4,731
﹤0.01% 3045
2024
Q3
$151K Hold
4,731
﹤0.01% 3076
2024
Q2
$388K Buy
4,731
+558
+13% +$60.3K ﹤0.01% 2805
2024
Q1
$605K Hold
4,173
﹤0.01% 2502
2023
Q4
$384K Sell
4,173
-1,111
-21% -$113K ﹤0.01% 2734
2023
Q3
$872K Sell
5,284
-687
-12% -$89.3K ﹤0.01% 2312
2023
Q2
$377K Buy
5,971
+561
+10% +$34K ﹤0.01% 2769
2023
Q1
$184K Sell
5,410
-20
-0.4% -$1.04K ﹤0.01% 2927
2022
Q4
$314K Buy
5,430
+2,170
+67% +$134K ﹤0.01% 2848
2022
Q3
$306K Hold
3,260
﹤0.01% 2857
2022
Q2
$727K Sell
3,260
-1
-0% -$335 ﹤0.01% 2511
2022
Q1
$1.79M Buy
3,261
+10
+0.3% +$6.04K ﹤0.01% 2152
2021
Q4
$2.15M Sell
3,251
-440
-12% -$336K ﹤0.01% 2094
2021
Q3
$3.1M Sell
3,691
-30
-0.8% -$30.4K ﹤0.01% 1888
2021
Q2
$4.72M Hold
3,721
﹤0.01% 1655
2021
Q1
$4.08M Buy
3,721
+30
+0.8% +$39.6K ﹤0.01% 1685
2020
Q4
$5.27M Buy
3,691
+460
+14% +$491K ﹤0.01% 1452
2020
Q3
$2.28M Sell
3,231
-89
-3% -$64.7K ﹤0.01% 1784
2020
Q2
$2.32M Buy
3,320
+1,610
+94% +$930K ﹤0.01% 1761
2020
Q1
$598K Buy
1,710
+70
+4% +$49.6K ﹤0.01% 2258
2019
Q4
$1.03M Sell
1,640
-230
-12% -$112K ﹤0.01% 2266
2019
Q3
$627K Hold
1,870
﹤0.01% 2449
2019
Q2
$486K Buy
1,870
+640
+52% +$128K ﹤0.01% 2617
2019
Q1
$203K Buy
+1,230
New +$200K ﹤0.01% 2903

Other funds holding CDLX

AllianceBernstein's CDLX Position: Q2 2025 in Review

AllianceBernstein sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 4,731 shares — an estimated $86.1K sold.

AllianceBernstein first reported a position in CDLX in Q1 2019 and held it in 25 quarters. The position peaked at $5.27M in Q4 2020. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • AllianceBernstein reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • AllianceBernstein sold 4,731 Cardlytics shares in Q2 2025, an estimated $86.1K.
  • AllianceBernstein first reported a position in Cardlytics in Q1 2019 and held it in 25 quarters.
  • AllianceBernstein's Cardlytics position peaked at $5.27M in Q4 2020.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.